ZIOPHARM Oncology (NASDAQ:ZIOP): Q3 GAAP EPS of -$0.43 misses by $0.34.
Cash & equivalents of $88.4M.
Thursday, November 7, 2019
Planet Fitness EPS in-line, beats on revenue
Planet Fitness (NYSE:PLNT): Q3 Non-GAAP EPS of $0.36 in-line; GAAP EPS of $0.31 misses by $0.01.
Revenue of $166.82M (+22.1% Y/Y) beats by $4.56M.
Shares +1.32%.
Pfenex EPS beats by $0.02, beats on revenue
Pfenex (NYSEMKT:PFNX): Q3 GAAP EPS of $0.09 beats by $0.02.
Revenue of $15.25M (+327.2% Y/Y) beats by $5.68M.
Dicerna Pharmaceuticals EPS misses by $0.17, misses on revenue
Dicerna Pharmaceuticals (NASDAQ:DRNA): Q3 GAAP EPS of -$0.45 misses by $0.17.
Revenue of $8.04M (+422.1% Y/Y) misses by $3.73M.
Cash, Cash Equivalents, and Marketable Securities of $312.7M
Spectrum Pharmaceuticals EPS beats by $0.17
Spectrum Pharmaceuticals (NASDAQ:SPPI): Q3 Non-GAAP EPS of -$0.22; GAAP EPS of -$0.24 beats by $0.17.
Cash & equivalents of $252M.
Penumbra EPS beats by $0.16, beats on revenue
Penumbra (NYSE:PEN): Q3 GAAP EPS of $0.32 beats by $0.16.
Revenue of $139.5M (+24.8% Y/Y) beats by $5.52M.
Amphastar Pharmaceuticals EPS beats by $0.03, beats on revenue
Amphastar Pharmaceuticals (NASDAQ:AMPH): Q3 Non-GAAP EPS of $0.10 beats by $0.03; GAAP EPS of $0.03.
Revenue of $80.14M (+6.1% Y/Y) beats by $1.61M.
Subscribe to:
Comments (Atom)